Current status of diagnosis and treatment of tuberculosis complicated with rheumatic diseases

doi:10.3969/j.issn.2095-3755.2018.02.002

Abstract

Abstract:

Rheumatic diseases are a heterogeneous group of conditions characterized by being autoimmune, indicating dysfunction or compromise of the patients’ immune system which is often further impaired by the use of hormones and immunosuppressants, leading to high susceptibility to tuberculosis infection. So it is necessary to raise awareness of rheumatic diseases and tuberculosis co-morbidity, the burden of which can be significantly reduced by conducting reasonable screening, diagnosis and treatment, getting a lower incidence and a higher cure rate.

Key words: Rheumatic diseases, Tuberculosis, Comorbidity, Multiphasic screening, Treatment outcome, Prognosis

Guo-fang DENG,Liang. FU. Current status of diagnosis and treatment of tuberculosis complicated with rheumatic diseases[J]. Journal of Tuberculosis and Lung Health , 2018, 7(2): 88-90. doi: 10.3969/j.issn.2095-3755.2018.02.002

References 16

[1]	杨华夏, 张丽帆, 刘晓清 , 等. 风湿性疾病的T细胞γ-干扰素释放分析诊断潜伏性结核分枝杆菌感染. 中华临床免疫和变态反应杂志, 2011,5(2):83-87. doi: 10.3969/j.issn.1673-8705.2011.02.001 URL
[2]	黄安芳, 罗妍, 赵毅 , 等. 风湿病患者合并潜伏性结核感染的分析. 中华内科杂志, 2016,55(4):307-310. doi: 10.3760/cma.j.issn.0578-1426.2016.04.012 URL
[3]	王子浔, 荣兰香, 马淑红 , 等. 风湿免疫性疾病患者行T-SPOT.TB检测筛查潜伏性结核感染的价值. 中国实验诊断学, 2017,21(3):512-514.
[4]	Gao L, Lu W, Bai L , et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015,15(3):310-319. doi: 10.1016/S1473-3099(14)71085-0 URL
[5]	邓国防, 王玉香, 陈涛 , 等. 风湿免疫性疾病并发结核感染的临床特征分析. 中国防痨杂志, 2018,40(4):392-396.
[6]	左晓霞 . 结缔组织疾病患者结核感染的研究现状与思考. 中华风湿病学杂志, 2009,13(10):657-659. doi: 10.3760/cma.j.issn.1007-7480.2009.10.001 URL
[7]	Lim CH, Chen HH, Chen YH , et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan . PLoS One, 12(6):e0178035.
[8]	Zhang Z, Fan W, Yang G , et al. Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials. BMJ Open, 2017,7(3):e012567. doi: 10.1136/bmjopen-2016-012567 URL
[9]	Yonekura CL, Oliveira RDR, Titton DC , et al. Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases ( Registro Brasileiro de Monitoração de Terapias Biológicas-BiobadaBrasil) . Rev Bras Reumatol Engl Ed, 2017,57 Suppl 2: 477-483. doi: 10.1016/j.rbr.2017.05.003 URL
[10]	Cantini F, Nannini C, Niccoli L , et al. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators Inflamm, 2017,2017:8909834.
[11]	边赛男, 刘晓清 . γ-干扰素释放试验在免疫功能抑制人群中诊断结核分枝杆菌感染的应用. 中华实验和临床感染病杂志(电子版), 2017,11(2):117-120. doi: 10.3877/cma.j.issn.1674-1358.2017.02.003 URL
[12]	Pyo J, Cho SK, Kim D , et al. Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases. Korean J Intern Med, 2017.
[13]	杨华 . 系统性红斑狼疮合并结核病临床分析. 医药卫生(全文版), 2017,3(4):30.
[14]	詹钟平, 劳敏曦, 苏凡 , 等. 系统性红斑狼疮合并结核的临床特征和相关因素分析. 实用医学杂志, 2017,33(21):3552-3555.
[15]	杨学英 . 58例强直性脊柱炎合并肺结核临床分析. 中国城乡企业卫生, 2017,33(11):62-63.
[16]	Júnior JCL, Ramos RTT, Robazzi TCMV . Treatment of latent tuberculosis in patients with juvenile rheumatic diseases: a systematic review. Rev Bras Reumatol Engl Ed, 2017,57(3):245-253. doi: 10.1016/j.rbr.2016.11.005 URL